nhtsa regulated Recalls
370 recalls tagged with “nhtsa regulated”.
Nivagen Zinc Oxide Ointment Recall 912 Containers Over cGMP Deviations (2025)
STRYKER NICO Myriad Handpiece Recall for 39,148 Units Worldwide (2026)
Tape used to secure components within packaging contains latex, despite products being labeled as latex-free. Latex could potentially cause an allergic reaction.

Olympus HX-400U-30 Recall: 7,803 Endoscopic Ligation Devices Recalled in 2025
Potential that the ligation loop was unable to release or detach as expected during use, causing the loop to become unintentionally fixed around patient anatomy.
B. Braun Medical Blood Administration Set Recall 7,344 Units Over Backflow Risk (2025)
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
BBraun Medical Blood Administration Set Recall 5,448 Units (2025)
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
B Braun Medical Recalls 12,168 IV Administration Sets for Backflow and Occlusion Risk (2025)
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
B. Braun Medical SAFELINE IV Sets Recalled for 46,250 Units Over Backflow Risk (2025)
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Philips Incisive CT Recall 2025: 2,341 CT Scanners Over Loose Tube Heat Exchanger Screws
Avion Pharmaceuticals Prenate Chewable Prenatal Vitamin Recalled for Undeclared Soy (804 Bottles, 5
Undeclared Soy. The firm received positive test results for soy which is not listed on the label. The firm also noticed that the amount of boron in the product is listed as 250mg per serving instead of 250mcg per serving.
B. Braun Medical Inc. IV Administration Set Recalled for Backflow and Priming Occlusion (490407)
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
B Braun Medical Inc. Recalls 28,344 IV Administration Sets Linked to Backflow and Occlusion Risks (Z
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
B. Braun Medical Recalls 32,500 Caresite Extension Sets for IV Pumps (2025)
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
B. Braun Medical Recalls 25,728 IV Administration Sets for Backflow and Occlusion Risk (2025)
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
BBMI IV Administration Sets Recalled in 2025 for Backflow and Occlusion Risk, 20.7 Million Units
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
B Braun Medical IV Administration Set Recall for Backflow Risk (490566) 2025
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
B Braun Medical IV Administration Sets Recall Over Backflow and Occlusion Risk (2025)
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Water Pure My Bladder Recall for E. coli Contamination — 17,612 Bottles (2025)
Product may be contaminated with E. coli O7:K1 (IAI39/ExPEC) and E. coli 1303
